TABLE 3.
Distribution of Individual Cumulative Doses among Cohort Participantsa
| Total number of workers | Hp(10) (mSv) | Colon (mGy) | Lung (mGy) | RBM (mGy) | Breast (mGy) (women only) | |
|---|---|---|---|---|---|---|
| Cohort | (percentage of exposed workers) | Mean (median; IQR) | Mean (median; IQR) | Mean (median; IQR) | Mean (median; IQR) | Mean (median; IQR) |
| France | 59,003 (72%) | 18.4 (2.1; 0.0,17.0) | 12.6 (1.4; 0.0,11.6) | 12.6 (1.4; 0.0,11.7) | 11.6 (1.3; 0.0,10.7) | 2.8 (0; 0.0,0.93) |
| UK | 147,866 (88%) | 28.7 (4.2; 0.6,2.4) | 19.9 (2.9; 0.4,14.1) | 19.8 (2.9; 0.4,14.1) | 18.2 (2.6; 0.4,12.9) | 5.1 (1.4; 0.4,4.3) |
| U.S. | 101,428 (83%) | 24.0 (2.9; 0.3,16.7) | 16.7 (2.1; 0.2,11.6) | 16.6 (2.0; 0.2,11.5) | 15.2 (1.9; 0.2,10.6) | 3.7 (0.4; 0.0,2.3) |
| Total | 308,297 (83%) | 25.2 (3.4; 0.4,18.4) | 17.4 (2.3; 0.3,12.8) | 17.4 (2.3; 0.3,12.7) | 15.9 (2.1; 0.3,11.7) | 4 (0.6; 0.0,2.8) |
Notes. Values include doses recorded as zero. RBM = red bone marrow. IQR = interquartile range (25th percentile, 75th percentile).
a
The cohort includes 268,262 men and 40,035 women.